UniProt ID | ERO1B_HUMAN | |
---|---|---|
UniProt AC | Q86YB8 | |
Protein Name | ERO1-like protein beta | |
Gene Name | ERO1B {ECO:0000312|HGNC:HGNC:14355} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 467 | |
Subcellular Localization |
Endoplasmic reticulum membrane Peripheral membrane protein Lumenal side . The association with ERP44 may be essential for its retention in the endoplasmic reticulum. |
|
Protein Description | Oxidoreductase involved in disulfide bond formation in the endoplasmic reticulum. Efficiently reoxidizes P4HB/PDI, the enzyme catalyzing protein disulfide formation, in order to allow P4HB to sustain additional rounds of disulfide formation. Other protein disulfide isomerase family members can also be reoxidized, but at lower rates compared to P4HB, including PDIA2 (50% of P4HB reoxidation rate), as well as PDIA3, PDIA4, PDIA6 and NXNDC12 (<10%). Following P4HB reoxidation, passes its electrons to molecular oxygen via FAD, leading to the production of reactive oxygen species (ROS) in the cell. May be involved in oxidative proinsulin folding in pancreatic cells, hence may play a role in glucose homeostasis.. | |
Protein Sequence | MSQGVRRAGAGQGVAAAVQLLVTLSFLRSVVEAQVTGVLDDCLCDIDSIDNFNTYKIFPKIKKLQERDYFRYYKVNLKRPCPFWAEDGHCSIKDCHVEPCPESKIPVGIKAGHSNKYLKMANNTKELEDCEQANKLGAINSTLSNQSKEAFIDWARYDDSRDHFCELDDERSPAAQYVDLLLNPERYTGYKGTSAWRVWNSIYEENCFKPRSVYRPLNPLAPSRGEDDGESFYTWLEGLCLEKRVFYKLISGLHASINLHLCANYLLEETWGKPSWGPNIKEFKHRFDPVETKGEGPRRLKNLYFLYLIELRALSKVAPYFERSIVDLYTGNAEEDADTKTLLLNIFQDTKSFPMHFDEKSMFAGDKKGAKSLKEEFRLHFKNISRIMDCVGCDKCRLWGKLQTQGLGTALKILFSEKEIQKLPENSPSKGFQLTRQEIVALLNAFGRLSTSIRDLQNFKVLLQHSR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
69 | Phosphorylation | KKLQERDYFRYYKVN HHHHHHCCEEEEECC | 9.00 | - | |
72 | Phosphorylation | QERDYFRYYKVNLKR HHHCCEEEEECCCCC | 9.57 | - | |
73 | Phosphorylation | ERDYFRYYKVNLKRP HHCCEEEEECCCCCC | 12.28 | - | |
122 | N-linked_Glycosylation | NKYLKMANNTKELED HHHHHHCCCCCCHHH | 53.88 | UniProtKB CARBOHYD | |
140 | N-linked_Glycosylation | ANKLGAINSTLSNQS HHHHHHHHHHCCCCC | 28.54 | 16263699 | |
145 | N-linked_Glycosylation | AINSTLSNQSKEAFI HHHHHCCCCCHHHHH | 53.94 | 16263699 | |
383 | N-linked_Glycosylation | EFRLHFKNISRIMDC HHHHHHCCHHHHHHH | 36.20 | UniProtKB CARBOHYD | |
404 | Phosphorylation | RLWGKLQTQGLGTAL HHHHHHHHCCHHHHH | 34.73 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ERO1B_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ERO1B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ERO1B_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ERP44_HUMAN | ERP44 | physical | 11847130 | |
PDIA1_HUMAN | P4HB | physical | 11847130 | |
PDIA1_HUMAN | P4HB | physical | 11707400 | |
PDIA2_HUMAN | PDIA2 | physical | 20802462 | |
PDIA3_HUMAN | PDIA3 | physical | 20802462 | |
PDIA4_HUMAN | PDIA4 | physical | 20802462 | |
ATP4A_HUMAN | ATP4A | physical | 26186194 | |
ERO1A_HUMAN | ERO1L | physical | 26186194 | |
FBX2_HUMAN | FBXO2 | physical | 26186194 | |
GPX4_HUMAN | GPX4 | physical | 26344197 | |
PSA4_HUMAN | PSMA4 | physical | 26344197 | |
ATP4A_HUMAN | ATP4A | physical | 28514442 | |
ERO1A_HUMAN | ERO1L | physical | 28514442 | |
FBX2_HUMAN | FBXO2 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Elucidation of N-glycosylation sites on human platelet proteins: aglycoproteomic approach."; Lewandrowski U., Moebius J., Walter U., Sickmann A.; Mol. Cell. Proteomics 5:226-233(2006). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-140, AND MASSSPECTROMETRY. |